Worldwide, elevated blood pressure (BP) is the strongest modifiable risk factor for cardiovascular disease and related disability 1 and a leading health risk. 2 The number of individuals with high BP and the estimated associated deaths have increased substantially over the past 25 years, 2 and are expected to continuously increase due to longer life expectancy and increased exposure to risk in the population. 1 More specifically, the burden of hypertension remains high in the presence of effective preventive interventions and low-cost antihypertensive medications. 2 To reduce the incidence, prevalence, and complications of hypertension in an aging society, novel strategies to improve the prevention, diagnosis, and control of the disorder are required. 1 Current guidelines for diagnosing hypertension mainly rely on BP measured at brachial arteries using cuff-based BP monitors. 3,4 However, BP measured at the central aorta may be a better correlate of target organ damages 5 and a prognostic factor for predicting future cardiovascular events than cuff brachial BP, as suggested by several epidemiological studies. [6] [7] [8] On the other hand, the superiority of central BP over brachial BP was not confirmed in other studies, 9 including a meta-analysis. 10 The inconsistent results may partly be explained by the inevitable measurement error of central BP introduced from the inaccurate cuff brachial BP measures that are required for the calibration of central BP. 11 Moreover, the differential central BP device types may also contribute the inconsistent results. Type I central BP devices OBJECTIVES Central blood pressure (BP) can be used to define hypertension. A central BP approach may be more sensitive than a conventional brachial BP approach in detecting hypertension. We aimed to compare the 2 approaches in estimating the prevalence hypertension in a nationally representative population.
estimate central BP relative to the measured brachial BP, and type II devices estimate the intra-arterial central BP. 11 The features are a relatively accurate pressure difference between central and peripheral sites for type I devices and a relatively accurate absolute central BP value for type II devices. 11 Based on long-term cardiovascular risks, central BP thresholds of 130/90 mm Hg for diagnosing hypertension have been derived and validated in independent cohorts, and the central hypertension has demonstrated a greater discriminatory power for long-term events. 12 Diagnosis of central hypertension is currently feasible with the availability of various noninvasive central BP devices, including several stand-alone cuff-based central BP monitors. 11 It has been recognized that noninvasive brachial systolic BP (SBP) may substantially underestimate invasive brachial SBP. [13] [14] [15] It is therefore likely that current practice of diagnosing hypertension based on the guidelines-recommended brachial BP criteria (≥140/90 mm Hg) may fail to detect a proportion of subjects with hypertension that requires medical treatment. 13, 14 Low hypertension detection rate with the cuff brachial BP approach is likely to underestimate the prevalence of hypertension and adversely impact the control of hypertension on a population level. On the other hand, a central BP approach using a stand-alone noninvasive cuff-based central BP monitor may have the potential to improve the diagnostic accuracy of hypertension. 13 Therefore, the purpose of the present study was to compare the 2 approaches (brachial and central BP with type II) in estimating the prevalence hypertension in a nationally representative population. We were particularly interested in estimating the prevalence of isolated central hypertension, namely, hypertension detected by the central BP approach but missed by the guideline-recommended brachial BP approach.
MATERIALS AND METHODS
National Nutrition and Health Survey (2013) (2014) (2015) (2016) in Taiwan (NAHSIT 2013 (NAHSIT -2016 was funded by Health Promotion Administration, Ministry of Health and Welfare in Taiwan. NAHSIT 2013-2016 was aimed to investigate the nutrition status and the association between nutrition/ diet and disease in residents in Taiwan. All residents in the National Household Registry in Taiwan were candidates, excluding those who lived in military institutes, medical institutes, schools, occupation/sport training centers, dormitories, and prisons. Enrolled subjects in the NAHSIT were selected using a multistage stratified sampling scheme. In stage I, each city/county in Taiwan was stratified into 2 levels by degree of urbanization. All villages/districts in the cities/ counties were sorted by population density and 2 villages/ districts per city/county were selected with the selection probability proportional to their size. To reduce the impact of diet changes with seasons, those cities/counties within the geographic homogeneity (North I/North II/Middle/South of Taiwan) were evenly scheduled for interview over 4 seasons. In stage II, area sampling was used. The initial household was randomly selected from the Household Registry list in the selected village/district. Then, households next to the initial household were surveyed until the designated number of subjects in each sex * age group was reached. In stage III, those candidates in the selected households were face-toface interviewed by well-trained interviewers at residents' houses. Each resident was firstly informed of the aims and potential benefits/risks of this survey, and then was asked to sign the informed consent before the interview. All subjects who had received the household interview were invited for a health check-up, included fasting blood biochemical and urine sample testing, and central and brachial BP measurements. A total of 2,742 residents aged more than 19 years attended the health check-up.
BP measurement and definitions of brachial and central hypertension
All participants were asked to refrain from exercise, smoking, and drinking tea or coffee before BP measurement. BP measurement was carried out in the morning while subjects had been seated and relaxed for 5 minutes with back and arms supported, legs uncrossed, and feet flat on the floor in a quiet room at each survey site for the health check-up. 3 All measurement sites followed the same protocol. Central and brachial BPs were measured simultaneously in the right arm with an appropriately sized cuff at heart level, using an oscillometric central BP monitor (WatchBP Office Central; Microlife AG, Widnau, Switzerland). 14 The central BP monitor measured brachial SBP and diastolic BP (DBP), performed pulse volume plethysmography at cuff pressure of 60 mm Hg to provide an ensemble average brachial pressure waveform, calibrated the ensemble average waveform to the brachial SBP and DBP, analyzed the calibrated waveform, and finally calculated central SBP and pulse pressure (PP) according to separate regression equations constructed from components of the analyzed waveform. 14, 16 The central BP monitor displayed readings of brachial SBP and DBP, central SBP and PP, and heart rate, each of which was an average from 2 consecutive measurements separated by an interval of 60 second. Central DBP was calculated as the difference between central SBP and PP. 14 Measurement accuracy of the standalone oscillometric central BP monitor with reference to the simultaneously measured invasive central BP in 85 subjects (255 measurements; age range, 30-93 years) has been previously reported. 14 The mean differences of central SBP, PP, and DBP with reference to the invasively measured central SBP, PP, and DBP were −0.6 ± 5.5, −0.4 ± 7.0, and −0.2 ± 6.5 mm Hg, respectively, without obvious systematic bias. 14 Brachial hypertension was defined as brachial SBP ≥140 mm Hg or DBP ≥90 mm Hg or using antihypertensive medications. 17 Prehypertension was defined as brachial SBP 120-139 mm Hg or DBP 80-89 mm Hg and without using antihypertensive medications. 17 Central hypertension was defined as central SBP ≥130 mm Hg or DBP ≥90 mm Hg or using antihypertensive medication. 12 Ten-year coronary heart disease risk score
The 10-year coronary heart disease risk score for everyone was calculated by a simple point system (18 total points) for the clinical model developed from 3,430 Chinese participants followed up for a median 15.9 years. 18 The performance of the clinical model, incorporating age (0-8 points), gender (0-2 points), body mass index (0-4 points), SBP (0-3 points), and smoking status (1 point), was not inferior to the cholesterol-based model and Framingham model in the external validation data set. 18 Because the point-based prediction model does not include an age category of <35 years, we assigned a zero point to subjects aged between 19 and 34 years, same as the age category of 35-39 years. 18 
Statistical methods
Means (±SD) and proportions were used to describe the characteristics of the sampled population. The student t-test and chi-squared test were used to examine the difference in intervals and proportions between genders, respectively. National weighted prevalence rates of central and brachial hypertension were estimated with 95% confidence intervals accounting for sampling scheme in the sampled population and in groups stratified by genders, age groups, and degrees of obesity, using SAS callable SUDDAN. We also estimated the standardized prevalence rates of central and brachial hypertension with World Health Organization (WHO) 2000 world standardized population. 19 Comparisons between subjects with concordant central and brachial nonhypertension, (n = 1,534), isolated central hypertension (n = 236), and concordant central and brachial hypertension (n = 958) were performed with t-test for interval variables or chi-squared test for categorical variables. Subjects with isolated brachial hypertension were not compared due to the very small sample size (n = 14).
Characteristics of the subjects with and without isolated central hypertension in subjects with brachial prehypertension were compared by t-test for interval variables or chisquared test for categorical variables. Logistic regression was used to investigate the determinants of central hypertension in the total population and subjects with brachial prehypertension. All statistical tests were set at a type I error of 5% and 2 tails. P values of <0.05 were considered statistically significant.
RESULTS
The characteristics of the study population are shown in Table 1 . Men were significantly older, had significantly high brachial and central SBP and DBP, body mass index, waist circumference, and levels of fasting triglycerides and glucose than women. Men also had significantly higher crude prevalence rates of brachial and central hypertension, and diabetes in comparison to women. Women had significantly higher levels of high-density lipoprotein cholesterol and total cholesterol than men. Brachial hypertension: brachial SBP ≥140 mm Hg or brachial DBP ≥90 mm Hg or using hypertensive medicines. Diabetes: fasting glucose ≥126 mg/dl or using diabetic medicines. Dyslipidemia: total cholesterol ≥200 mg/dl or LDL-cholesterol ≥130 mg/dl or using lipids lowering drugs. Abbreviations: DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PP, pulse pressure; SBP, systolic blood pressure.
a The prevalence rates were not weighted according to the sampling scheme.
The WHO standardized prevalence of central hypertension was 27.95%, which was significantly higher than that of brachial hypertension (20.80%, P < 0.0001) ( Table 2) . The national weighted prevalence of central hypertension among adults aged more than 19 years in Taiwan was 32.48%, which was also significantly higher than that of brachial hypertension (25.43%, P < 0.0001) ( Table 2 ). The awareness, treatment, and control rates of brachial hypertension were 72.06%, 89.35%, and 49.90% (among treated and untreated hypertensives), respectively (Supplementary Table S1 ). Central and brachial hypertension prevalence rates in men (37.18% and 29.91%, respectively) were significantly higher than those in women (28.15% and 21.30%, respectively) (all P < 0.001) ( Table 2 ). The prevalence rates of central and brachial hypertension increased with age and body mass index strata (Table 2) . Multivariable analysis revealed that older age, male gender, higher body mass index, larger waist circumference, and higher fasting glucose levels were independently associated with central hypertension (Supplementary Table S2 ).
The diagnosis of hypertension using both the brachial BP and central BP approaches resulted in 4 BP groups, based on the presence or absence of central and brachial hypertension. The crude proportion of concordant central and brachial hypertension was 34.94% (n = 958), of concordant central and brachial nonhypertension, 55.94% (n = 1,534), of isolated central hypertension, 8.61% (n = 236), and of isolated brachial hypertension, 0.51% (n = 14). The national weighted prevalence of concordant central and brachial hypertension was 25.13%, of concordant central and brachial nonhypertension, 67.22%, of isolated central hypertension, 7.35%, and of isolated brachial hypertension, 0.30%.
Characteristics of the subjects with isolated brachial hypertension are shown in Supplementary Tables S3 and  S4 . Subjects with isolated central hypertension were about 10 years older, had significantly higher brachial and central BPs, body mass index, waist circumference, levels of fasting triglycerides and glucose, had significantly lower highdensity lipoprotein cholesterol level, and had significantly more men, diabetes, dyslipidemia, and greater 10-year coronary heart disease risk score (Table 3 ) (Figure 1 ), when compared with subjects in the concordant nonhypertension group ( Table 3 ). The 2 groups had similar low-density lipoprotein cholesterol and total cholesterol levels. On the other hand, subjects with isolated central hypertension were about 10 years younger, had significantly lower brachial and central SBP and DBP, waist circumference, had less diabetes and lower 10-year coronary heart disease risk score than subjects in the concordant hypertension group (Table 3 ) (Figure 1 ). Subjects with isolated central hypertension group had similar brachial and central PP, body mass index, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol, and glucose levels as compared to subjects in the concordant hypertension group.
Subjects in the concordant nonhypertension and hypertension groups could further be divided into the normal and prehypertension subgroups, and stage 1 and stage 2 hypertension subgroups, respectively (Supplementary Figure S1 , Table S5 ). Subjects with isolated central hypertension had an age-and sex-adjusted 10-year coronary heart disease risk score that was equivalent to that of subjects with stage 1 hypertension, and significantly higher than that of subjects with prehypertension (Supplementary Figure S1) .
The prevalence of isolated central hypertension did not significantly vary with age and sex (Figure 2 ). Among 236 subjects with isolated central hypertension, 229 (97%) had a brachial BP within the range of prehypertension defined by brachial SBP 120-139 mm Hg and DBP 80-89 mm Hg, and only 7 (3%) had normal BP (SBP < 120 mm Hg and DBP < 80 mm Hg). 17 In contrast, among 603 subjects with brachial prehypertension, only 229 (38.0%) had isolated central hypertension.
Subjects with brachial prehypertension and central hypertension were significantly older, had significantly higher brachial and central SBP and PP, body mass index, waist circumference, fasting plasma glucose level, and had more women than subjects with prehypertension but without central hypertension (Table 4 ). Multivariable analysis revealed that older age, female sex, overweight/obese, and high fasting glucose levels were significant independent determinants of central hypertension among subjects with brachial prehypertension (Supplementary Table S6 ).
DISCUSSION
To our knowledge, this is the first study reporting the prevalence rates of hypertension defined by central BP in a nationally representative sample. The national weighted prevalence of central hypertension was 32.48%, which was significantly higher than that of brachial hypertension (25.43%). The prevalence of isolated central hypertension, hypertension detected only by the central BP approach, was 7.35% and did not vary with age and sex (Figure 2) . Subjects with isolated central hypertension had a 10-year coronary heart disease risk score that was equivalent to that of subjects with stage 1 hypertension and was significantly higher than that of subjects with prehypertension. Lowering the brachial hypertension diagnostic threshold to include all subjects with prehypertension could identify 97% of subjects with isolated central hypertension. However, this loose brachial BP approach may not be practical because about 2/3 of subjects with prehypertension would not have central hypertension.
Almost one-third of the enrolled subjects in the NAHSIT selected using a multistage stratified sampling scheme had brachial hypertension (crude rate 35.45%, Table 1 ). However, the age-standardized prevalence rate of brachial hypertension, calculated using the WHO standard population, was 20.80% (Table 2) , substantially lower than the world averaged prevalence of 31.1% (95% confidence interval, 30.0-32.2%) in 2010. 20 Therefore, the prevalence of brachial hypertension in Taiwan is not considered particularly high in the AsiaPacific region or among the world's countries.
In the present study, average central SBP was higher than brachial SBP (124.1 mm Hg vs. 121.9 mm Hg) in total population, which might appear inconsistent with the well-recognized SBP amplification phenomenon. However, according to a recent individual participant data meta-analysis, cuff brachial BP underestimated intra-arterial brachial SBP by 5.7 mm Hg (95% confidence interval: −8.0 to −3.5 mm Hg). 15 Because the Microlife WatchBP Office Central purported to estimate the intra-arterial central BP, and therefore is categorized as a type II central BP device according to the ARTERY Society task force consensus statement. 11 The noninvasive central SBP estimated using central BP device type II may be higher than noninvasive brachial cuff SBP, due to underestimation of true (intra-arterial) brachial SBP with the cuff device. 11
Central hypertension
Central BP may reflect more accurately the hemodynamic stress on target organs than brachial BP and a recent metaanalysis of cross-sectional data showed that central SBP and PP were more closely associated with left ventricular mass index, carotid intima-media thickness, and pulse-wave velocity than the corresponding brachial BP. 21 In several prospective studies, central SBP and/or PP had a stronger association with cardiovascular events than brachial BP. 6, 7, 22, 23 More specifically, hypertension defined by central SBP/DBP ≥130/90 mmHg was associated with a greater contribution to the predictive power for cardiovascular events than by brachial SBP/DBP ≥140/90 mm Hg in an independent cohort of 2,501 community-based untreated individuals with a median follow-up of 10 years. 12 Few studies have reported both prevalence rates of central hypertension and brachial hypertension. 24 An unpublished cross-sectional study of 1928 consecutive untreated patients from a hypertension clinic (mean age, 51 years; women, 52%) reported that 54% patients had concordant brachial and central nonhypertension, 34% concordant brachial and central hypertension, 4% isolated central hypertension, and 8% isolated brachial hypertension. 24 Overall, the prevalence rate of brachial hypertension (42%) was slightly higher than that of central hypertension (38%). 24 In contrast, the present study suggests that the guidelinesrecommended brachial BP-based approach may underestimate the national prevalence of hypertension by 7%, which is of major public health concern and deserves further actions to improve hypertension control.
Isolated central hypertension
In a large data set of 10,613 healthy subjects and subjects with hypertension, hypercholesterolemia, smoking, diabetes, or cardiovascular disease, over 70% of individuals with BP values in the prehypertension range had central SBP in common with individuals with stage 1 hypertension. 25 Even in the health subjects, a significant and highly variable difference between central and brachial SBP existed at all ages, and a large overlap in central SBP despite no overlap in brachial SBP was observed. 22 It is thus expected that we may be treating some subjects with brachial hypertension and relatively low central BP, and not treating individuals with central hypertension and relatively low brachial BP. 22 The present study indeed identified and characterized a group of subjects with central but not brachial hypertension in a nationally representative sample. Subjects with the isolated central hypertension may have a cardiovascular risk profile equivalent to that of those with stage 1 brachial hypertension but significantly worse than those with prehypertension. It remains to be determined whether the long-term cardiovascular risk of isolated central hypertension is like that of stage 1 brachial hypertension and deserves pharmacological treatment. Alternatively, isolated central hypertension may represent an advanced stage of prehypertension that deserves aggressive intervention. The category of brachial prehypertension recommended by hypertension guidelines 17 has been considered as a risk factor for future hypertension and cardiovascular events. [26] [27] [28] The present study suggests that isolated central hypertension may represent the higher risk subjects among those with brachial prehypertension and may thus be useful in risk-stratification. Conversely, brachial prehypertension had a high sensitivity (97.03%), a moderate specificity (75.62%), and a very high false discovery rate (62.13%) in the prediction of the concomitant central hypertension. This may suggest that isolated central hypertension cannot be predicted with sufficient accuracy from brachial BP and needs to be assessed directly. 22 Moreover, lowering the brachial hypertension diagnostic threshold to 130/85 mm Hg may reduce the prevalence of isolated central hypertension while increase the prevalence of isolated brachial hypertension (Supplementary Table S6) , and may not improve the agreement between the brachial and central BP approaches in the diagnosis of hypertension.
Epidemiological studies have consistently demonstrated a progressive convergence of central and brachial SBP with advancing age, due to the age-related decrease in PP amplification. 22, 29 The high correlation and small mean difference between the central and brachial SBP in advanced age may suggest that measurement of central BP is not as useful in the elderly as in the younger adults. 30 However, the prevalence of isolated central hypertension did not decline with age in men and women in the present study (Figure 2) . Therefore, our results may support the use of central BP to improve hypertension detection at all ages.
Isolated brachial hypertension
Subjects with isolated brachial hypertension have not been characterized, except those in the subgroup of isolated systolic hypertension in the young adults. 31, 32 In the subgroup of isolated systolic hypertension and normal central BP, the high elasticity of the vascular tree may play a mechanistic role in the youth, but the exaggerated PP amplification from central to peripheral arteries is less observed with increasing age. 32 Overall, increased cardiac output and stroke volume, but not exaggerated PP amplification, are the predominant hemodynamic disturbances in young adults with isolated systolic hypertension, and most with high central BP. 31 In the present study, only 14 (0.51%) subjects with isolated brachial hypertension were identified, in contrast to 236 (8.61%) subjects with isolated central hypertension. All subjects with isolated brachial hypertension were untreated and had elevated brachial DBP and most had isolated diastolic hypertension (Supplementary Tables S3 and S4) , which is a consequence of an increase in arteriolar resistance and is the most frequent form of hypertension in the population <40 years old. 33 Our results may suggest that the prevalence of isolated diastolic hypertension without central hypertension is very low and its clinical significance remains to be determined.
Limitations of the present study
Many noninvasive devices have been developed to estimate central BP using different techniques. 11 The prevalence rates of central hypertension in the present study were estimated using a specific type II central BP device. It is likely that the estimated prevalence rates were device specific, namely, different results may be obtained when using different devices. 11 This is an important issue that has recently been addressed in a consensus statement relating to methods for assessing and reporting the accuracy of central BP devices. 11 The validation protocol of the current central BP monitor actually complied with the recommendations of the consensus statement. 11 Moreover, the performance of the central BP monitor in the diagnosis of hypertension was shown to be superior to that of the brachial BP with a higher sensitivity and negative predictive value. 13 The present study confirmed the prediction that a considerable proportion of hypertensive subjects may only be identifiable through noninvasive central BP measurements from the central BP monitor. 13 The present study was carried out in an ethnic Chinese population in Taiwan, therefore, the results may be not generalizable to other ethnics.
In conclusion, about one-third population had hypertension in the nationally representative adult population, using a central BP approach. About 7% of hypertension was diagnosed by the central BP approach but not detected by the conventional brachial BP approach. Since subjects with the isolated central hypertension may have a cardiovascular risk profile like that of stage 1 brachial hypertension. Further research is needed to confirm the clinical significance of isolated central hypertension and the relevance of implementing the central BP approach in the diagnosis of hypertension and hypertension control programs.
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